{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:43:07Z","timestamp":1791776587152,"version":"4.3.4"},"reference-count":18,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T00:00:00Z","timestamp":1288310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> For HLA\u2010alloimmunized patients, platelet (PLT) concentrations are provided either at matched HLA\u2010A and HLA\u2010B loci or by serologic cross\u2010reactivity groups (CREG) matching strategy. However, this method has some limitations.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> In this study, the epitope\u2010based matching (EBM) method was evaluated for selecting proper HLA\u2010typed PLTs for patients with PLT transfusion refractoriness. Bead\u2010based single\u2010antigen HLA antibody detection method and HLAMatchmaker software were used to define the epitopes recognized by HLA\u2010specific antibodies and to select compatible PLTs for nine patients with alloimmunized refractoriness. Corrected count increments (CCIs) were prospectively determined to compare successful transfusion rates among different matching methods in 142 PLT transfusions. In addition, HLA antibodies were serially detected to see whether any emerging antibodies appeared after receiving the EBM\u2010matched PLTs.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> The transfusion success rates evaluated with 1\u2010hour CCIs for perfect matching or lacking any mismatching at HLA\u2010A and \u2010B locus (A\/BU)\u2010matched, CREG\u2010matched, and EBM\u2010matched PLTs were 85.2, 63.2, and 83.7%, respectively. Compared to CREG\u2010matched PLTs, EBM\u2010matched PLTs showed better transfusion results (p\u2003=\u20030.035). In the follow\u2010up study (7 months; range, 3\u201013 months), no emerging HLA\u2010specific antibodies were detected after receiving EBM\u2010matched PLTs.<\/jats:p><jats:p><jats:bold>CONCLUSIONS:<\/jats:bold> EBM performed on the basis of bead\u2010based single\u2010antigen HLA antibody detection coupled with the HLAMatchmaker program is recommended in choosing proper PLTs for refractory patients when A\/BU\u2010matched PLTs were not available.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2010.02703.x","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T00:20:52Z","timestamp":1274919652000},"page":"2318-2327","source":"Crossref","is-referenced-by-count":40,"title":["Epitope\u2010based matching for HLA\u2010alloimmunized platelet refractoriness in patients with hematologic diseases"],"prefix":"10.1111","volume":"50","author":[{"given":"Shun\u2010Chung","family":"Pai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyh\u2010Chyi","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su\u2010Jen","family":"Lin Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u2010Sheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong\u2010Tsamn","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo\u2010Sin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang\u2010In","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,29]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2724"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07189.x"},{"key":"e_1_2_8_4_2","first-page":"221","article-title":"Transfusion therapy of refractory thrombcytopenic patients with platelets from donors selectively mismatched for cross\u2010reactive HLA antigens","volume":"9","author":"Duquesnay RJ","year":"1977","journal-title":"Transplant Proc"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1992.32792391036.x"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03387.x"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01516.x"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-4080"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01837.x"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830020303"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2006.08.001"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40121446.x"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39070772.x"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1980.tb00291.x"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199712253372601"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0940"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402075"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000278721.97037.1e"},{"key":"e_1_2_8_19_2","volume-title":"HLA beyond tears: introduction to human histocompatibility","author":"Rodey GE","year":"2000"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2010.02703.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2010.02703.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T13:05:43Z","timestamp":1697288743000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2010.02703.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,29]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1111\/j.1537-2995.2010.02703.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2010.02703.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,29]]}}}